Kimble Jenkins's most recent trade in ClearPoint Neuro Inc was a trade of 547 Common Stock done at an average price of $5.7 . Disclosure was reported to the exchange on Sept. 30, 2020.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
ClearPoint Neuro Inc | Kimble Jenkins | Director | Grant, award, or other acquisition of securities at price $ 5.71 per share. | 30 Sep 2020 | 547 | 49,043 (0%) | 0% | 5.7 | 3,123 | Common Stock |
ClearPoint Neuro Inc | Kimble Jenkins | Director | Grant, award, or other acquisition of securities at price $ 3.55 per share. | 30 Jun 2020 | 879 | 48,496 (0%) | 0% | 3.5 | 3,120 | Common Stock |
ClearPoint Neuro Inc | Kimble Jenkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2020 | 15,000 | 15,000 | - | - | Stock Options (right to buy) |